EANS-DD: AGENNIX AG
Notification concerning transactions by persons performing
managerial responsibilities pursuant to section 15a of the WpHG
-------------------------------------------------------------------------------- Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement: --------------------------------------------------------------------------------
Person, triggering the disclosure:
-----------------------------
Name: James D. Weaver
(natural person)Reason for the disclosure requirement: ------------------------------ Reason: Person performing managerial responsibilities Position: Member of an administrative or supervisory body
Details of the transaction: --------------------------------------------------------------------------------
Transaction: ------------ Description of financial instrument: Shares of Agennix AG
ISIN: DE000A1A6XX4
Type of transaction: sales
Date: 27.10.2010
Currency: Euro
Price: 1.00000
No of items: 150432
Total amount traded: 150,432.00000
Place: OTC
Explanation: The shares were sold to dievini Hopp BioTech holding GmbH
& Co. KG in connection with the subscription for 19,244,641
new shares by dievini Hopp BioTech holding GmbH & Co. KG in
the course of the capital increase in Agennix AG.
Of the overall 150,432 sold shares, 14,064 shares are
directly allocated to James D. Weaver, 36,110 shares are
allocated to James D. Weaver as trustee with sole power of
disposition of several trusts created under the laws of
Texas and 100,258 shares are allocated to James D. Weaver
as trustee with joint power of disposition together with
Margaret W. Weaver of several trusts created under the laws
of Texas.Further inquiry note: ----------------- Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com
Issuer subject to the publication requirement: --------------------------------------------------------------------------------
end of announcement euro adhoc --------------------------------------------------------------------------------
Further inquiry note:
Branche: Pharmaceuticals
ISIN: DE000A1A6XX4
WKN: A1A6XX
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade
Original-Content von: AGENNIX AG i.L., übermittelt durch news aktuell